UCB's Global Corporate Website

UCB is a Proud Sponsor of SPIN 2022!

Posted by
Owen Davies, Immuno-Dermatology, UCB

We are pleased to sponsor and participate in the 7th Congress of the Skin Inflammation and Psoriasis International Network (SPIN) which starts today in Paris, France and runs until 8th July. Every three years, the SPIN Congress gathers circa 1,500 delegates from around 90 countries, and this year it will take place in a new hybrid format, enabling participants to join physically and online.

The SPIN congress has a focus on chronic inflammatory skin diseases including psoriasis, atopic dermatitis, vitiligo, alopecia, and hidradenitis suppurativa. At this year’s congress, UCB has a busy programme of three sponsored symposia focused on psoriasis with the titles and timings summarised below:

  1. Possibilities for Personalized Care in Women Living with Psoriasis: what else can be done? Thursday, 7th July - 12:45–13:45 CEST
  2. Reaching New Heights: Team-driven approaches elevating patient care in psoriasis. Thursday, 7th July – 18:00-19:00 CEST
  3. Reaching new heights: Expecting more from treatment options in psoriasis. Friday, 8th July 2022 - 12:45–13:45 CEST.

In addition to our symposia, we are delighted to have 12 presentations at the congress. The data to be presented include the latest results from clinical studies across our dermatology portfolio that highlight our commitment to addressing unmet needs and elevating standards of care.

SPIN 2022 promises to be an inspiring and stimulating event with the opportunity to hear perspectives on daily medical practice from all over the world. We are proud to be a part of a scientific community that is focused on challenging current thinking and exploring new management strategies in order to improve the lives of those with painful and debilitating skin conditions.

If you are a healthcare professional attending SPIN 2022, do join us at the UCB exhibition booth. Our team looks forward to welcoming you!


Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.


Enter the characters shown in the image.